会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Compositions and methods for topical application and transdermal delivery of an oligopeptide
    • 用于局部应用和透皮递送寡肽的组合物和方法
    • US08022179B2
    • 2011-09-20
    • US11368198
    • 2006-03-03
    • Michael D. DakeJacob M. Waugh
    • Michael D. DakeJacob M. Waugh
    • A61K38/08A61K38/10A61K31/74A61K39/08C07K4/00
    • A61K9/7023A61K8/64A61K38/08A61Q7/00A61Q15/00C07K14/33
    • The invention relates to the transdermal application of oligopeptides for reducing synaptic transmission in tissues of an animal. In one aspect, this invention relates to compositions comprising an oligopeptide and optionally a carrier comprising a positively charged “backbone” having positively charged branching or “efficiency” groups, as described herein. Most preferably the positively charged carrier is a long-chain positively charged polypeptide or a positively charged nonpeptidyl polymer, for example, a polyalkyleneimine. The invention further relates methods for producing a biologic effect of reducing synaptic transmission in a tissue by topically applying an effective amount of such a composition, preferably to the skin, of a subject or patient in need of such treatment. This invention also provides kits for preparing or formulating a composition that comprises the oligopeptide and optionally a carrier, as well as such additional items that are needed to produce a usable formulation, or a premix that may in turn be used to produce such a formulation.
    • 本发明涉及用于减少动物组织中突触传递的寡肽的透皮应用。 一方面,本发明涉及包含寡肽和​​任选的载体的组合物,其包含具有带正电荷的支化或“效率”基团的带正电荷的“骨架”,如本文所述。 最优选地,带正电荷的载体是长链带正电荷的多肽或带正电荷的非肽基聚合物,例如聚亚烷基亚胺。 本发明还涉及用于通过局部施用有效量的这种组合物,优选给予需要这种治疗的受试者或患者的皮肤来产生减少组织中突触传递的生物学效应的方法。 本发明还提供用于制备或配制包含寡肽和​​任选的载体的组合物的试剂盒,以及产生可用制剂所需的其它物质,或可以依次用于制备这种制剂的预混物。
    • 8. 发明授权
    • Thoracic graft and delivery catheter
    • 胸腔移植和输送导管
    • US5693083A
    • 1997-12-02
    • US358067
    • 1994-12-15
    • Steve G. BakerMichael D. DakeDavid C. DillowArnold Escano
    • Steve G. BakerMichael D. DakeDavid C. DillowArnold Escano
    • A61B17/11A61F2/00A61F2/04A61F2/82A61F2/06
    • A61F2/07A61B17/11A61F2/04A61F2/82A61F2/95A61F2/958A61F2/966A61M25/10A61F2/848A61F2/89A61F2002/075A61F2002/3008A61F2002/30451A61F2002/8486A61F2002/9511A61F2002/9517A61F2220/0016A61F2220/0058A61F2220/0075A61F2250/0098A61M2025/1068
    • A delivery catheter having an inner catheter assembly, an inferior capsule catheter, and a capsule jacket assembly for use in deploying a graft having a compressible and expandable attachment systems in the thoracic region of an aorta. The graft is comprised of a tubular member having superior and inferior ends, each having an attachment system with wall engaging members secured thereto and is crimped along its midsection to resist kinking and elongation. The delivery catheter includes an inferior capsule assembly for releasably retaining the inferior attachment system of the graft and a superior capsule assembly for releasably retaining the superior attachment system of the graft as well as a releasing system for maintaining the attachment systems in a compressed configuration and for facilitating expansion of the attachment systems. The delivery catheter also includes an anti-elongation wire attached to the inner catheter assembly to prevent stretching of the delivery catheter during deployment of the graft within the aorta. Upon removing the attachment systems from the capsule, the releasing system functions to allow the attachment systems to assume their expanded configuration and engage the walls of the aorta. The graft and attachment systems remain in the vessel after the delivery catheter is withdrawn.
    • 具有内导管组件,下胶囊导管和胶囊护套组件的输送导管,其用于部署具有在主动脉的胸部区域中的可压缩和可扩张的附接系统的移植物。 移植物由具有上端和下端的管状构件组成,每个管状构件具有固定到其上的壁接合构件的附接系统,并沿其中部卷曲以抵抗扭结和伸长。 递送导管包括用于可释放地保持移植物的下部附接系统的下部胶囊组件和用于可释放地保持移植物的上部附接系统的上部胶囊组件以及用于将附着系统保持在压缩构型中的释放系统,并且 促进附件系统的扩展。 递送导管还包括附接到内导管组件的抗延伸丝,以防止在将主动脉内的移植物展开期间伸出导管。 在从胶囊中取出附接系统时,释放系统的作用是允许附接系统呈现它们的扩张构型并且接合主动脉的壁。 输送导管拔出后,移植物和附着系统保留在血管内。